logo

Canadian News

Share SHARE

The Canadian stock market is rising in early trade Friday. The market rallied earlier this week, but closed near the unchanged level yesterday. Healthcare and information technology stocks are among the best performing stocks this morning, while mining and gold stocks are lagging behind. Investors...

The U.S. dollar strengthened against its most major rivals in mid-European trading on Friday, after data showed that the U.S. economy expanded faster than the initial estimate in the first quarter, supporting expectations of a Federal Reserve interest rate increase in June. Data from the Commerce...

Early signals are mixed for Canadian stocks Friday morning after strong gains earlier in the week. The Bay Street rally paused in the previous session and traders may be reluctanct to keep buying ahead of a closely-watched speech from US Federal Reserve boss Janet Yellen. Yellen, who speeks at...

Loblaw Co. Ltd. (L.TO), a Canadian food and pharmacy company, announced Friday that it has completed a strategic review of its gas bar operations, and will engage potential buyers in considering a sale of the business. Loblaw's gas bar network consists of 212 retail fuel sites located adjacent to...

The Canadian dollar continued to be lower against its key counterparts in European trading on Friday. The loonie fell to 2-day lows of 1.4583 versus the euro, 1.3048 versus the greenback and 0.9422 against the aussie, compared to yesterday's closing values of 1.4526, 1.2977 and 0.9376, respectively. The...

Cameco Corp. (CCO.TO, CCJ) signed an agreement with Joint Stock Company National Atomic Company Kazatomprom and Joint Venture Inkai LLP to restructure and enhance JV Inkai. The new agreement replaces the memorandum of agreement signed by Cameco and Kazatomprom in September 2012. Cameco's ownership interest...

The Japanese yen strengthened against the other major currencies in the early European session on Friday. The yen rose to a 2-day high of 160.54 against the pound, from an early low of 161.42. Against the euro, the Swiss franc and the NZ dollar, the yen advanced to 122.58, 110.73 and 73.79 from...

Nerv-HighRisk-052716.jpg Shares of Minerva Neurosciences Inc. (NERV) rocketed up over 270% on Thursday, touching a new high of $13.22, thanks to positive phase II trial results of its drug candidates MIN-101 and MIN-117.

The Canadian dollar weakened against the other major currencies in the Asian session on Friday amid oil prices slide, due to global oversupply concerns. Crude oil for July delivery are currently down $0.37 to $49.11 a barrel. Meanwhile, investors waited for clues about the next U.S. interest rate...

Aldeyra Therapeutics Inc. (ALDX) has offered to sell 2.4 million shares of its common stock to the public at a price of $5.00 each. The offering is expected to close on or about June 1, 2016. Aldeyra has granted the underwriter a 30-day option to purchase 360,000 additional shares of common stock.

The Canadian dollar weakened against the other major currencies in the Asian session on Friday. The Canadian dollar fell to a 2-day low of 0.9389 against the Australian dollar, from yesterday's closing value of 0.9376. Against the U.S. dollar and the euro, the loonie dropped to 1.2999 and 1.4544...

Pharma-050516.jpg Shares of Titan Pharmaceuticals Inc. (TTNP) were up over 20% in extended trading on Thursday, following FDA approval of Probuphine implant for the treatment of opioid dependence.

The Canadian stock market rally ran out of gas Thursday on speculation recent gains were overdone. Unofficially, the benchmark S&P/TSX Composite Index inched down 4.5 points or 0.03 percent to 14,049. The heavyweight Financial Index was flat despite strong earnings from Canada's biggest banks. Royal...

The Canadian stock market is rising in early trade Wednesday, adding to the gains of the previous two sessions, but is off its early highs. Rising commodity prices are a source of strength for the market in early action. Financial stocks are also in focus after three of Canada's largest banks reported...

ValeantCorporateController-052616.jpg Canadian drug maker Valeant Pharmaceuticals International, Inc. said it has appointed Sam Eldessouky as senior vice president and corporate controller, with effect from May 31, 2016. The appointment is the latest in a raft of management changes at the company, which has been criticized for its accounting and business practices.

Follow RTT